Experimental Two-Shot vaccine trial launches for Tough-to-Treat bowel cancers
NCT ID NCT07417488
Summary
This is an early-stage safety study testing a new two-part cancer vaccine strategy. It is for adults with advanced colorectal or small bowel cancer that has continued to grow despite standard treatments. The main goal is to find a safe dose and see if the body's immune system reacts to the vaccines.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.